Author

Kamal V Patel

Institution: St George’s University Hospitals NHS Foundation Trust

Observed institutions: St George's Hospital, St George’s University Hospitals NHS Foundation Trust

ORCID: 0000-0003-2611-4260

Observed ORCID: 0000-0003-2611-4260

OpenAlex ID: A5107943708

Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional “step-up” care for patients with active Crohn’s disease: a cost-effectiveness analysis from the PROFILE trial

2025 · Nurulamin M Noor, Neil Davies, et al. · Journal of Crohn s and Colitis · 13

Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort study

2022 · Shaji Sebastian, Kamal V Patel, et al. · BMJ Open Gastroenterology · 11

Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib

2023 · Zhigang Liu, James L Alexander, et al. · Journal of Crohn s and Colitis · 10

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn’s disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial

2026 · Megha Bhandari, Mohmmed Tauseef Sharip, et al. · Journal of Crohn s and Colitis · 3

Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn’s disease

2026 · Nurulamin M Noor, Haiyan Zheng, et al. · Journal of Crohn s and Colitis · 1

Tu1445: EFFECT OF PHARMACOKINETICS AND IMMUNOGENICITY ON CLINICAL AND ENDOSCOPIC EFFICACY IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SEAVUE STUDY

2022 · Remo Panaccione, Bruce E. Sands, et al. · Gastroenterology · 1

414: Higher Neoplasia Detection Rate and Lower Number of Targeted Biopsies Associated With Virtual Chromoendoscopy in Ibd Surveillance: a Large, Multicentre Real-world Uk Study

2025 · Chandni Radia, Andrew T. King, et al. · Gastroenterology

Su1882: RELAPSE OF ULCERATIVE COLITIS ON DOSE REDUCTION OF TOFACITINIB IS ASSOCIATED WITH MARKERS OF T CELL ACTIVATION BUT NOT CLINICAL FEATURES: A PROSPECTIVE, MULTICENTRE OBSERVATIONAL STUDY

2025 · Sailish Honap, Sangmi Kim, et al. · Gastroenterology

Su1912: REAL-WORLD APPLICATION OF OBJECTIVE MOTILITY MRI FOR MEASURING TRANSMURAL HEALING IN SMALL BOWEL CROHN’S DISEASE: INSIGHTS INTO GASTROENTEROLOGISTS’ TREATMENT ASSESSMENT FROM THE CONTEXT TRIAL

2025 · Alex Menys, Iyad Naim, et al. · Gastroenterology

Su1857: A COST-EFFECTIVENESS ANALYSIS OF ANTI-TNF TREATMENT FROM DIAGNOSIS IN PATIENTS WITH MODERATE AND SEVERE CROHN’S DISEASE: AN ANALYSIS USING DATA FROM THE PROFILE TRIAL

2025 · Nurulamin Noor, Neil Davies, et al. · Gastroenterology

Tu1738 ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE BY BASELINE DISEASE SEVERITY

2023 · Britta Siegmund, Kamal V Patel, et al. · Gastroenterology

Su1720 COMPARATIVE EFFICACY AND SAFETY OF UPADACITINIB VERSUS TOFACITINIB AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A MATCHING-ADJUSTED INDIRECT COMPARISON

2023 · Walter Reinisch, Jacinda N. Tran, et al. · Gastroenterology

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB

2022 · James L. Alexander, Nick Kennedy, et al. · Gastroenterology

1134: Pre-operative Oral Enteral Nutritional Optimisation for Crohn's Disease: a Retrospective Uk Tertiary Ibd Centre Cohort Study

2022 · Susanna Meade, Kamal V Patel, et al. · Gastroenterology

Works count: 14

Citation count: 39

H-index: 3

I10-index: 3